HomeComparePOND vs JNJ

POND vs JNJ: Dividend Comparison 2026

POND yields 18.02% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 POND wins by $44.6K in total portfolio value
10 years
POND
POND
● Live price
18.02%
Share price
$11.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$64.6K
Annual income
$5,421.64
Full POND calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — POND vs JNJ

📍 POND pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPONDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, POND + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
POND pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

POND
Annual income on $10K today (after 15% tax)
$1,531.53/yr
After 10yr DRIP, annual income (after tax)
$4,608.39/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, POND beats the other by $3,904.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of POND + JNJ for your $10,000?

POND: 50%JNJ: 50%
100% JNJ50/50100% POND
Portfolio after 10yr
$42.3K
Annual income
$3,124.71/yr
Blended yield
7.38%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

POND
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

POND buys
0
JNJ buys
0
No recent congressional trades found for POND or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPONDJNJ
Forward yield18.02%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$64.6K$20.0K
Annual income after 10y$5,421.64$827.78
Total dividends collected$34.8K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: POND vs JNJ ($10,000, DRIP)

YearPOND PortfolioPOND Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,502$1,801.80$10,676$355.77+$1.8KPOND
2$15,482$2,105.21$11,407$389.39+$4.1KPOND
3$19,002$2,436.52$12,198$426.53+$6.8KPOND
4$23,127$2,794.89$13,056$467.62+$10.1KPOND
5$27,925$3,179.07$13,987$513.12+$13.9KPOND
6$33,468$3,587.47$14,998$563.56+$18.5KPOND
7$39,829$4,018.19$16,098$619.52+$23.7KPOND
8$47,086$4,469.06$17,295$681.69+$29.8KPOND
9$55,319$4,937.71$18,599$750.82+$36.7KPOND
10$64,613$5,421.64$20,022$827.78+$44.6KPOND

POND vs JNJ: Complete Analysis 2026

PONDStock

Angel Pond Holdings Corporation focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on target businesses within technology-enabled sectors, including e-commerce; enterprise software and cloud computing; and fintech. The company was incorporated in 2021 and is based in New York, New York.

Full POND Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this POND vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

POND vs SCHDPOND vs JEPIPOND vs OPOND vs KOPOND vs MAINPOND vs ABBVPOND vs MRKPOND vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.